SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

12 Jan 2017 Evaluate

Fredun Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on January 18, 2017, to consider obtaining on lease a property for storage purposes for a period of 12 months; to consider the matter of obtaining a Loan from Fredun Healthcare; and to consider the matter of obtaining a Loan from one or more NBFC(s) if required.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

2150.05 39.20 (1.86%)
24-Apr-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1621.10
Dr. Reddys Lab 1317.55
Cipla 1285.95
Zydus Lifesciences 929.50
Lupin 2270.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×